Immunoassay Market Worth $49.6 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In June 2022, Roche received Emergency Use Authorization from the FDA for the Cobas SARS-CoV- 2 Duo for use on the fully automated Cobas 6800/8800 Systems.
View full press release